حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Health and Happiness (H&H) International Holdings Ltd
1112Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care, adult nutrition and care, and pet nutrition and care products in China, Australia, New Zealand, North America, and internationally. The company offers milk formulas for infants, children and expectant, and nursing mothers; probiotic and nutrition supplements in the form of sachets, capsules, gummies, and tablets for infants, children, and expectant mothers; and vitamins, herbal and mineral supplements, and skin care and sports nutrition products for adults; dried baby food and baby care products; and complete pet food products, and multicondition pet supplements. In addition, the company is involved in the research, development, manufacture, sale, and processing of meat, fruit, vegetable powder, candy, special nutritional food, and nutritional products; marketing and distribution of organic baby food; and wholesale, retail, import, and export of nutritional food and personal care products for infants. Further, it engages in the trading and sale of vitamins, health supplements, skin care and sports nutrition products for adults, pet food, and nutritional supplements for pets; online sale and provision of software and information technology; and packaging services, as well as research, development, procurement and sale of vitamins, health supplements, skin care and sports nutrition products for adults. It provides its products under the Healthy Times, Biostime Changsha, Farmland, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, and Good Gout brand names. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited. Address: One Island East, Quarry Bay, Hong Kong
Analytics
سعر الهدف في وول ستريت
96.54 HKDنسبة السعر إلى الأرباح
22.383العائد الربحي
4.96 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية 1112
تحليلات الأرباح 1112
نمو الأرباح على مدى 5 سنوات
–النمو المستمر
1 سنةمعدل الدفع 5 سنوات في المتوسط
68 %تاريخ الأرباح 1112
تقييم الأسهم 1112
المالية 1112
نتائج | 2019 | ديناميات |